LTGO’s Onzotrigine shows rapid, superior acute pain relief in late-stage trials
TradingView News reports Onzotrigine (LTGO) is in late-stage trials for acute pain, citing superior efficacy, rapid onset and opioid-sparing potential. It also notes LTG-321 is progressing in chronic pain.